Video | 15 February 2020 Big pharma is double dipping 1 min RESEARCH AND DEVELOPMENT Medicines made with help from OUR taxes should be accessible to EVERYONE who needs them. SHARE this video and tell our leaders to stand up to Big Pharma’s double-dip profiteering. Share this message! Tell your leaders: We won’t pay twice for medicines any more. Share on Read, watch, share Filter by - Any -BlogEventsFeature storyInfographicLetterNewsletterOpinion articlePress releaseReportResearch articleSpeechSpotlightStatementTechnical briefTopic overviewVideo Technical brief | 22 May 2023 Research and development Roundtable: Disclosing Clinical Trial Costs – Why and How Should It Be Done? Statement | 01 February 2023 Research and development MSF Statement on EB152/7 - Substandard and falsified medical products 1 min Statement | 01 February 2023 Research and development MSF Statement on EB152/13 - Strengthening clinical trials to provide high-quality evidence on health interventions and to improve research quality and coordination 1 min Statement Statement | 17 November 2022 Research and development MSF publishes first Clinical Trial Transparency Policy 5 min Events Events | 17 November 2022 Research and development How can disclosing clinical trial costs increase access to medical products? Technical brief | 11 November 2022 Transparency Research and development MSF Clinical Trial Transparency Policy Technical brief | 17 October 2022 Research and development Roundtable: How Can Disclosing Clinical Trial Costs Increase Access to Medical Products? Blog Blog | 05 October 2022 Research and development South Africa can and must demand better deals for drug clinical trials — lives depend on it Load More
Technical brief | 22 May 2023 Research and development Roundtable: Disclosing Clinical Trial Costs – Why and How Should It Be Done?
Statement | 01 February 2023 Research and development MSF Statement on EB152/7 - Substandard and falsified medical products 1 min
Statement | 01 February 2023 Research and development MSF Statement on EB152/13 - Strengthening clinical trials to provide high-quality evidence on health interventions and to improve research quality and coordination 1 min
Statement Statement | 17 November 2022 Research and development MSF publishes first Clinical Trial Transparency Policy 5 min
Events Events | 17 November 2022 Research and development How can disclosing clinical trial costs increase access to medical products?
Technical brief | 11 November 2022 Transparency Research and development MSF Clinical Trial Transparency Policy
Technical brief | 17 October 2022 Research and development Roundtable: How Can Disclosing Clinical Trial Costs Increase Access to Medical Products?
Blog Blog | 05 October 2022 Research and development South Africa can and must demand better deals for drug clinical trials — lives depend on it
